Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis
Ji Y. Son(California State University Los Angeles), David S. Hong(The University of Texas MD Anderson Cancer Center), Kate J. Krause(The University of Texas MD Anderson Cancer Center), Amadeo B. Biter(The University of Texas MD Anderson Cancer Center), Mirella Nardo(The University of Texas MD Anderson Cancer Center), Goldy C. George(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center)
Cited by 20
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508
AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer
|Science Translational Medicine|2015|438
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
|Journal of Clinical Oncology|2020|391